PIEZO1 and demyelinating disease: Notably, studies have shown that pharmacological activation of PIEZO1 channels can induce demyelination while blocking PIEZO1 channels can prevent axonal and myelin damage in the CNS and also alleviate secondary progressive neurodegeneration following demyelinating diseases (Velasco-Estevez et al., 2020).